THE PROGNOSTIC SIGNIFICANCE OF P21 AND HER-2 GENE EXPRESSION AND MUTATION/POLYMORPHISM IN PATIENTS WITH GASTRIC CARCINOMA

Basit Öğe Kaydı
dc.authoridÖzen, Alaattin/0000-0001-9219-6001
dc.authoridPuyan, Fulya/0000-0001-5853-0109
dc.authoridÖzen, Alaattin/0000-0001-9219-6001
dc.authoridOz Puyan, Fulya/0000-0001-5853-0109
dc.authoridIbis, Cem/0000-0002-5602-375X
dc.authorwosidÖzen, Alaattin/IZQ-0388-2023
dc.authorwosidPuyan, Fulya/V-7074-2019
dc.authorwosidKocak, Zafer/AEG-7828-2022
dc.authorwosidÖzen, Alaattin/ABG-9988-2020
dc.authorwosidOz Puyan, Fulya/A-7077-2018
dc.authorwosidIbis, Cem/AAE-3388-2020
dc.contributor.authorOzen, Alaattin
dc.contributor.authorKocak, Zafer
dc.contributor.authorSipahi, Tammam
dc.contributor.authorOz-Puyan, Fulya
dc.contributor.authorCakina, Suat
dc.contributor.authorSaynak, Mert
dc.contributor.authorIbis, Cem
dc.date.accessioned2024-06-12T11:23:38Z
dc.date.available2024-06-12T11:23:38Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.descriptionEuropean-Society-for-Medical-Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer -- JUN 22-25, 2011 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.endpagev43en_US
dc.identifier.issn0923-7534
dc.identifier.startpagev43en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26562
dc.identifier.volume22en_US
dc.identifier.wosWOS:000291260100118en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleTHE PROGNOSTIC SIGNIFICANCE OF P21 AND HER-2 GENE EXPRESSION AND MUTATION/POLYMORPHISM IN PATIENTS WITH GASTRIC CARCINOMAen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu